ArticleMolecular cancer2023

Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial.

Eelke M Bos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.